Log In
BCIQ
Print this Print this
 

IO101

  Manage Alerts
Collapse Summary General Information
Company IO Biotech ApS
DescriptionPeptide vaccine encompassing an HLA-A2-restricted, 9 amino acid IDO-derived CD8+ T-cell epitope
Molecular Target Indoleamine 2,3-dioxygenase (INDO) (IDO)
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Peptide vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today